{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:20:07Z","timestamp":1788841207356,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Annual influenza vaccination is recommended, but its efficacy in dialysis population is still controversial. Here we aimed to compare the dynamic changes of immune response between various influenza vaccination protocols in hemodialysis patients. A 18-week open label, non-randomized, controlled trial was conducted during 2011\u20132012. The efficacy between unvaccinated, one- and two-dose regimens were evaluated in 175 hemodialysis patients. Immunogenic profiles were assessed by hemagglutination-inhibition assays. At 3\u20139 weeks post-vaccination, antibody responses were similar between the one- and two-dose regimens, while the seroprotection rates (antibody titer \u22651:40) for influenza A were 55.6\u201382.5% in the adult (18\u201360 years) and 33.3\u201366.7% in the elderly (&gt;60 years). Meanwhile, the seroprotection rates for influenza B were low (4.0\u201325.0%). By 18 weeks post-vaccination, the seroprotection rates for influenza A and B declined (0.0\u201333.3%) in both the adult and elderly receiving one- or two-dose regimens. Of dialysis patients, at most 2.4% developed moderate to severe adverse effects(myalgia and headache) after vaccination. In conclusion, the two-dose regimen could not improve immune responses than the one-dose regimen in hemodialysis patients; meanwhile the induced protective antibodies of both regimens could not be maintained for more than 4 months. Modification of current influenza vaccination strategy in dialysis population should be re-considered.<\/jats:p>","DOI":"10.1038\/srep20725","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T11:57:01Z","timestamp":1455278221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Changes of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients \u2013 an 18-week, open-label trial"],"prefix":"10.1038","volume":"6","author":[{"given":"Yu-Tzu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Te","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Song","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiang Lin","family":"Wen-Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-En","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Hui","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eing-Ju","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junne-Ming","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"BFsrep20725_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrg2053","volume":"8","author":"MI Nelson","year":"2007","unstructured":"Nelson, M. I. & Holmes, E. C. The evolution of epidemic influenza. Nat. Rev. Genet. 8, 196\u2013205 (2007).","journal-title":"Nat. Rev. Genet."},{"key":"BFsrep20725_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrmicro1819","volume":"6","author":"GB Karlsson Hedestam","year":"2008","unstructured":"Karlsson Hedestam, G. B. et al. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat. Rev. Microbiol. 6, 143\u2013155 (2008).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFsrep20725_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1353\/bhm.2002.0022","volume":"76","author":"NP Johnson","year":"2002","unstructured":"Johnson, N. P. & Mueller, J. Updating the accounts: global mortality of the 1918-1920 \u201cSpanish\u201d influenza pandemic. Bull. Hist. Med. 76, 105\u2013115 (2002).","journal-title":"Bull. Hist. Med."},{"key":"BFsrep20725_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1086\/590567","volume":"47","author":"A Trilla","year":"2008","unstructured":"Trilla, A., Trilla, G. & Daer, C. The 1918 \u201cSpanish flu\u201d in Spain. Clin. Infect. Dis. 47, 668\u2013673 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep20725_CR5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","volume":"58","author":"MJ Sarnak","year":"2000","unstructured":"Sarnak, M. J. & Jaber, B. L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 58, 1758\u20131764 (2000).","journal-title":"Kidney Int."},{"key":"BFsrep20725_CR6","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1056\/NEJMcp0807498","volume":"359","author":"WP Glezen","year":"2008","unstructured":"Glezen, W. P. Clinical practice. Prevention and treatment of seasonal influenza. N. Engl. J. Med. 359, 2579\u20132585 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep20725_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/j.ajkd.2012.09.001","volume":"60","author":"LJ McGrath","year":"2012","unstructured":"McGrath, L. J. & Kshirsagar, A. V. Influenza and pneumococcal vaccination in dialysis patients: merely a shot in the arm? Am. J. Kidney Dis. 60, 890\u2013892 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep20725_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1046\/j.1523-1755.2003.00787.x","volume":"63","author":"DT Gilbertson","year":"2003","unstructured":"Gilbertson, D. T. et al. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 63, 738\u2013743 (2003).","journal-title":"Kidney Int."},{"key":"BFsrep20725_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1053\/j.ajkd.2012.04.018","volume":"60","author":"TC Bond","year":"2012","unstructured":"Bond, T. C., Spaulding, A. C., Krisher, J. & McClellan, W. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am. J. Kidney Dis. 60, 959\u2013965 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep20725_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/archinternmed.2011.2238","volume":"172","author":"LJ McGrath","year":"2012","unstructured":"McGrath, L. J. et al. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch. Intern. Med. 172, 548\u2013554 (2012).","journal-title":"Arch. Intern. Med."},{"key":"BFsrep20725_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ije\/dyi274","volume":"35","author":"LA Jackson","year":"2006","unstructured":"Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M. & Weiss, N. S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int. J. Epidemiol. 35, 337\u2013344 (2006).","journal-title":"Int. J. Epidemiol."},{"key":"BFsrep20725_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.ajkd.2008.11.032","volume":"54","author":"J Scharpe","year":"2009","unstructured":"Scharpe, J. et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am. J. Kidney Dis. 54, 77\u201385 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep20725_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00430-012-0231-8","volume":"201","author":"U Ott","year":"2012","unstructured":"Ott, U. et al. Serological response to influenza A H1N1 vaccine (Pandemrix(R)) and seasonal influenza vaccine 2009\/2010 in renal transplant recipients and in hemodialysis patients. Medi. Microbiol. Immunol. 201, 297\u2013302 (2012).","journal-title":"Medi. Microbiol. Immunol."},{"key":"BFsrep20725_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000045713","volume":"86","author":"JA Antonen","year":"2000","unstructured":"Antonen, J. A. et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 86, 56\u201361 (2000).","journal-title":"Nephron"},{"key":"BFsrep20725_CR15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ki.1978.170","volume":"14","author":"EO Osanloo","year":"1978","unstructured":"Osanloo, E. O. et al. Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney Int. 14, 614\u2013618 (1978).","journal-title":"Kidney Int."},{"key":"BFsrep20725_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-94-007-4549-0_35","volume":"756","author":"A Mastalerz-Migas","year":"2013","unstructured":"Mastalerz-Migas, A., Steciwko, A. & Brydak, L. B. Immune response to influenza vaccine in hemodialysis patients with chronic renal failure. Adv. Exp. Med. Biol. 756, 285\u2013290 (2013).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFsrep20725_CR17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.vaccine.2003.11.046","volume":"22","author":"NP Vogtlander","year":"2004","unstructured":"Vogtlander, N. P., Brown, A., Valentijn, R. M., Rimmelzwaan, G. F. & Osterhaus, A. D. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 22, 2199\u20132201 (2004).","journal-title":"Vaccine"},{"key":"BFsrep20725_CR18","doi-asserted-by":"publisher","first-page":"c147","DOI":"10.1159\/000312878","volume":"115","author":"J Eiselt","year":"2010","unstructured":"Eiselt, J., Kielberger, L., Sedlackova, T., Racek, J. & Pazdiora, P. High ferritin, but not hepcidin, is associated with a poor immune response to an influenza vaccine in hemodialysis patients. Nephron Clin. Pract. 115, c147\u2013153 (2010).","journal-title":"Nephron Clin. Pract."},{"key":"BFsrep20725_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/00365590310008749","volume":"37","author":"C Cavdar","year":"2003","unstructured":"Cavdar, C. et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J. Urol. Nephrol. 37, 71\u201376 (2003).","journal-title":"Scand J. Urol. Nephrol."},{"key":"BFsrep20725_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/jmv.20936","volume":"79","author":"E Tanzi","year":"2007","unstructured":"Tanzi, E. et al. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J. Med. Virol. 79, 1176\u20131179 (2007).","journal-title":"J. Med. Virol."},{"key":"BFsrep20725_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000093306","volume":"26","author":"JY Song","year":"2006","unstructured":"Song, J. Y. et al. Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am. J. Nephrol. 26, 206\u2013211 (2006).","journal-title":"Am. J. Nephrol."},{"key":"BFsrep20725_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/bmj.294.6568.348","volume":"294","author":"DJ Versluis","year":"1987","unstructured":"Versluis, D. J. et al. Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis. Br. Med. J. 294, 348 (1987).","journal-title":"Br. Med. J"},{"key":"BFsrep20725_CR23","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1016\/j.vaccine.2012.05.016","volume":"30","author":"YT Chang","year":"2012","unstructured":"Chang, Y. T. et al. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients. Vaccine 30, 5009\u20135018 (2012).","journal-title":"Vaccine"},{"key":"BFsrep20725_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1053\/j.ajkd.2010.11.031","volume":"57","author":"R Dikow","year":"2011","unstructured":"Dikow, R. et al. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. Am. J. Kidney Dis. 57, 716\u2013723 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep20725_CR25","unstructured":"European Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP\/BWP\/214\/96). London: European Agency for the Evaluation of Medicinal Products. (1997). Available at http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003945.pdf. (Accessed: 22 October 2014)."},{"key":"BFsrep20725_CR26","unstructured":"European Committee for Proprietary Medicinal Products. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorization application (CPMP\/VEG\/4717\/03). London: European Agency for the Evaluation of Medicinal Products. (2004). Available at http:\/\/archives.who.int\/prioritymeds\/report\/append\/62EMEAguidelines.pdf. (Accessed: 22 October 2014)."},{"key":"BFsrep20725_CR27","unstructured":"World Health Organization. Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. (2011). Available at http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241548090_eng.pdf. (Accessed: 22 October 2014)."},{"key":"BFsrep20725_CR28","unstructured":"Center for Biologics Evaluation and Research. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines. Bethesda, MD: Food and Drug Administration. (2007). Available at http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm091985.pdf. (Accessed 22 October 2014)"},{"key":"BFsrep20725_CR29","doi-asserted-by":"crossref","unstructured":"National Kidney, F. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. Am. J. Kidney Dis. 66, 884\u2013930 (2015).","DOI":"10.1053\/j.ajkd.2015.07.015"},{"key":"BFsrep20725_CR30","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1093\/ndt\/gfr013","volume":"26","author":"YT Chang","year":"2011","unstructured":"Chang, Y. T. et al. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases. Nephrol. Dial. Transplant. 26, 3588\u20133595 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFsrep20725_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1086\/524146","volume":"197","author":"DM Skowronski","year":"2008","unstructured":"Skowronski, D. M., Tweed, S. A. & De Serres, G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J. Infect. Dis. 197, 490\u2013502 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFsrep20725_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/clinids\/5.4.737","volume":"5","author":"TR Cate","year":"1983","unstructured":"Cate, T. R., Couch, R. B., Parker, D. & Baxter, B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines\u20141978. Rev. Infect. Dis. 5, 737\u2013747 (1983).","journal-title":"Rev. Infect. Dis."},{"key":"BFsrep20725_CR33","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/0264-410X(96)00061-8","volume":"14","author":"W Kunzel","year":"1996","unstructured":"Kunzel, W., Glathe, H., Engelmann, H. & Van Hoecke, C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14, 1108\u20131110 (1996).","journal-title":"Vaccine"},{"key":"BFsrep20725_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ndt\/gfg012","volume":"18","author":"JA Antonen","year":"2003","unstructured":"Antonen, J. A. et al. Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults. Nephrol. Dial. Transplant. 18, 777\u2013781 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFsrep20725_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(95)91434-X","volume":"346","author":"AE Ahmed","year":"1995","unstructured":"Ahmed, A. E., Nicholson, K. G. & Nguyen-Van-Tam, J. S. Reduction in mortality associated with influenza vaccine during 1989\u201390 epidemic. Lancet 346, 591\u2013595 (1995).","journal-title":"Lancet"},{"key":"BFsrep20725_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0272-6386(00)70006-0","volume":"35","author":"H Kaul","year":"2000","unstructured":"Kaul, H., Girndt, M., Sester, U., Sester, M. & Kohler, H. Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am. J. Kidney Dis. 35, 611\u2013616 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep20725_CR37","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1046\/j.1523-1755.2001.59780206.x","volume":"78","author":"M Girndt","year":"2001","unstructured":"Girndt, M., Sester, M., Sester, U., Kaul, H. & Kohler, H. Molecular aspects of T- and B-cell function in uremia. Kidney Int. Suppl. 78, S206\u2013211 (2001).","journal-title":"Kidney Int. Suppl."},{"key":"BFsrep20725_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000065873","volume":"45","author":"V Kovacic","year":"2002","unstructured":"Kovacic, V., Sain, M. & Vukman, V. Efficient haemodialysis improves the response to hepatitis B virus vaccination. Intervirology 45, 172\u2013176 (2002).","journal-title":"Intervirology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep20725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20725","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:52:01Z","timestamp":1672890721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep20725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,2,22]]}},"alternative-id":["BFsrep20725"],"URL":"https:\/\/doi.org\/10.1038\/srep20725","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"assertion":[{"value":"21 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20725"}}